Polymer conjugates: nanosized medicines for treating cancer
Top Cited Papers
- 1 January 2006
- journal article
- review article
- Published by Elsevier in Trends in Biotechnology
- Vol. 24 (1) , 39-47
- https://doi.org/10.1016/j.tibtech.2005.11.006
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Polyvalent dendrimer glucosamine conjugates prevent scar tissue formationNature Biotechnology, 2004
- Polymeric anticancer drugs with pH-controlled activationAdvanced Drug Delivery Reviews, 2004
- AP-5346Drugs of the Future, 2004
- HPMA Copolymer-Anticancer Drug-OV-TL-TL16 Antibody Conjugates. 1. Influence of the Method of Synthesis on the Biding Affinity to OVCAR-3 Ovarian Carcinoma CellsIn VitroJournal of Drug Targeting, 2003
- Block copolymers with amino acid sequences: Molecular chimeras of polypeptides and synthetic polymersThe European Physical Journal E, 2003
- Selective anticancer drugsNature Reviews Drug Discovery, 2002
- Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrierEuropean Journal Of Cancer, 1995
- Polymeric Drug-Carriers Containing Doxorubicin and Melanocyte-Stimulating Hormone:In VitroandIn VivoEvaluation Against Murine MelanomaJournal of Drug Targeting, 1993
- Modification of E. coli L-asparaginase with polyethylene glycol: Disappearance of binding ability to anti-asparaginase serumBiochemical and Biophysical Research Communications, 1978
- Structure and properties of pharmacologically active polymersJournal of Polymer Science: Polymer Symposia, 1975